Search results
Results from the WOW.Com Content Network
(Reuters) -The U.S. Food and Drug Administration has granted approval to a treatment from Verona Pharma for a chronic lung disease that commonly affects smokers, the U.K.-based company said on ...
(Reuters) -Verona Pharma said on Thursday its therapy for a chronic and potentially fatal lung disease will have a wholesale price of $2,950 per month, above the estimated cost-effectiveness range ...
Ensifentrine, sold under the brand name Ohtuvayre, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD) in adults. [1] It is a phosphodiesterase 3 inhibitor and phosphodiesterase 4 inhibitor. [1]
David Ebsworth is non-executive chairman at Verona Pharma Plc. His career spans over 35 years in the global pharmaceutical industry, during which he was Global Head of Pharmaceuticals at Bayer AG and CEO of a number of companies, including ViforPharma and Galenica. He is also an advisor to a variety of CEOs at public and private organisations.
WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced positive interim 16-week data for the ongoing Phase 2 VERONA clinical trial evaluating ...
Jones was a postdoctoral researcher between 1967 and 1968. From 1972 until 1975, Jones was head of development at The Boots Co Ltd.During his time there he was responsible for the technical development of several new products, notably Prothiaden (antidepressant) and Froben (anti-inflammatory), a range of generic products and the technology transfer of Brufen/Nurofen (anti-inflammatory) to many ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
WASHINGTON (Reuters) -President Donald Trump's foreign aid pause has forced a suspension of flights for more than 40,000 Afghans approved for special U.S. visas and at risk of Taliban retribution ...